Skip to content

Feasibility, Acceptance and Preliminary Efficacy of the Multimodal AKTIVER Heart Delirium Prevention Program in Patients Following Cardiac Surgery: Randomized Controlled PREVENT POstoperative Delirium (PREVENT-POD) Study

Feasibility, Acceptance and Preliminary Efficacy of the Multimodal AKTIVER Heart Delirium Prevention Program in Patients Following Cardiac Surgery: Randomized Controlled PREVENT POstoperative Delirium (PREVENT-POD) Study - PREVENT-POD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00035091
Enrollment
60
Registered
2024-11-04
Start date
2024-11-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium in patients following cardiac surgery F05

Interventions

Group 1: Intervention group with AKTIVER Heart intervention - Multimodal, non-pharmacological delirium prevention program with the following modules: 1. Optimization of the medical perioperative manag
2. Optimization of the psychological preparation
3. Orientation visits
4. Intensive mobilization
5. Activation visits
6. Meal support during eating
7. Relaxation and sleep
8. Support/company during medical examinations (AKTIVER Heart) Group 2: Control group with education about the admission for cardiac surgery and postoperative delirium/prevention of postoperative deli

Sponsors

Klinik für Herz-, Thorax- und Gefäßchirurgie der Universitätsmedizin Göttingen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged = 65 years undergoing elective cardiac surgery (with or without heart-lung machine, with or without sternotomy, surgery duration > 60 min) 2. Ability to provide an informed consent 3. Willingness to voluntarily participate in the study after informed consent with signed informed consent form 4. Sufficient knowledge of the German language to complete/answer the questionnaires

Exclusion criteria

Exclusion criteria: 1. Ability to sign informed consent form 2. Severe dementia; severe mental disorders (acute psychosis, severe depressive depressive episode, acute suicidal tendencies), acute delirium 3. Diagnosis of acute alcohol or drug abuse 4. Unstable angina pectoris, STEMI or NSTEMI within the last 2 weeks 5. Heart failure, NYHA IV 6. Severe refractory cardiac arrhythmias 7. Advanced (metastasized) oncological disease 8. Participation in another intervention study (participation in registry studies is permitted)

Design outcomes

Primary

MeasureTime frame
1. Feasibility of the AKTIVER Heart intervention - this is assumed if 90% of patients in the AKTIVE Heart intervention group (N=36) have received preoperative information on perioperative procedures, postoperative delirium and preoperative somatic (optimization by the cardiac surgeons) and psychological preparation (approx. 10-14 days before the planned procedure) and postoperatively at least 1 module per day after extubation for a period of five postoperative days. 2. Acceptance of the AKTIVER Heart intervention - this is assumed if a mean value of acceptance of the intervention is rated by patients on a scale of 0-10 (0=not at all acceptable; 10=very acceptable) with an average of = 7.0. 3. Feasibility of the study design - this is assumed, if an average of 1 patient per week is randomized into the study (36 patients in 36 weeks, 24 in the intervention group, 12 in the control group - 2:1 randomization) and at least 75% of the randomized patients complete all assessments at the 3-month follow-up.

Secondary

MeasureTime frame
Exploratory analyses of group differences between the AKTIVER Heart and the TAU+ group in the following variables: Delirium incidence (3-D-CAM, CAM-ICU, 4-AT), delirium severity (CAM-S, DRS-R-98), cognition (MoCA, SMI), psychological variables and sleep (HADS, PSQI, IES-R), disease acceptance and treatment expectation (IPQ, TEX-Q), nutrition (MNA), frailty (CSHA frailty index), sarcopenia (SARC-F, hand strength measurement), length of stay in the ICU and normal unit.

Countries

Germany

Contacts

Public ContactMonika Sadlonova

Klinik für Herz-, Thorax- und Gefäßchirurgie der Universitätsmedizin Göttingen

monika.sadlonova@med.uni-goettingen.de0551-39-67231

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026